Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
Fábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2006
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial
Martin J van den Bent, Antoine F Carpentier, Alba A Brandes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
Matti Aapro, Alain Astier, Riccardo Audisio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Nature Medicine
|
January 6, 2026
Reduce bureaucracy in clinical trials now
Martin Dreyling, Sara Badreh Wirström, Wolfgang E Berdel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951
Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
The Lancet. Healthy Longevity
|
November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults
Michael Denkinger, Wilma Knol, Antonio Cherubini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 3, 2022
QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer
Sarah M Kelly, Rachel Effeney, Mark N Gaze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
The Lancet. Oncology
|
March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E Hegi, Warren P Mason, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
May 3, 2025
Defining the role of pragmatic clinical trials in cancer clinical research: outcomes of a collaborative workshop hosted by the European Organisation for Research and Treatment of Cancer
Fábio Cardoso Borges, Winette T A van der Graaf, Robbe Saesen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2006
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial
Martin J van den Bent, Antoine F Carpentier, Alba A Brandes, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 11, 2017
Identifying critical steps towards improved access to innovation in cancer care: a European CanCer Organisation position paper
Matti Aapro, Alain Astier, Riccardo Audisio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2024
Academic Uphill Battle to Personalize Treatment for Patients With Stage II/III Triple-Negative Breast Cancer
Marleen Kok, Robbert-Jan Gielen, Sylvia Adams, et al.
Nature Medicine
|
January 6, 2026
Reduce bureaucracy in clinical trials now
Martin Dreyling, Sara Badreh Wirström, Wolfgang E Berdel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 17, 2012
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951
Martin J van den Bent, Alba A Brandes, Martin J B Taphoorn, et al.
The Lancet. Healthy Longevity
|
November 17, 2023
Inclusion of functional measures and frailty in the development and evaluation of medicines for older adults
Michael Denkinger, Wilma Knol, Antonio Cherubini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 3, 2022
QUARTET: A SIOP Europe project for quality and excellence in radiotherapy and imaging for children and adolescents with cancer
Sarah M Kelly, Rachel Effeney, Mark N Gaze, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors
Andrew B Lassman, Khê Hoang-Xuan, Mei-Yin C Polley, et al.
The Lancet. Oncology
|
March 10, 2009
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp, Monika E Hegi, Warren P Mason, et al.
Page
of 12